Reuters logo
BRIEF-CSL says new data demonstrate prophylactic treatment with idelvion reduces bleed frequency
July 12, 2017 / 1:20 PM / 4 months ago

BRIEF-CSL says new data demonstrate prophylactic treatment with idelvion reduces bleed frequency

July 12 (Reuters) - CSL Ltd:

* Says new data demonstrate prophylactic treatment with idelvion reduces bleed frequency

* Says data shows idelvion has potential to positively impact patients with haemophilia B

* CSL - additional data shows idelvion prophylaxis regimens result in high rates of compliance, reduced consumption compared with previous fix

* CSL Ltd - additional data shows that idelvion prophylaxis regimens result in improvement in paediatric health-related quality of life Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below